Cell-specific expression of TLR9 isoforms in inflammation

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 76-86

  McKelvey, Kelly J ^a   Highton, John ^b   Hessian, Paul A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Inflammation; Rheumatoid arthritis; Toll like receptor 9

Indexed keywords

TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR 9A; TOLL LIKE RECEPTOR 9C; TOLL LIKE RECEPTOR 9D; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MALE; MITOCHONDRION; MONOCYTE; NUCLEOTIDE SEQUENCE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SUBCUTANEOUS NODULE; SYNOVITIS; T LYMPHOCYTE;

AGED; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; BASE SEQUENCE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONOCYTES; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 79151479087     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.11.001     Document Type: Article

References (62)

1. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K., Monks B., Knetter C., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190-198.
2. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 2004, 34:251-262.
3. Gursel M., Verthelyi D., Gursel I., Ishii K., Klinman D. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol 2002, 71:813-820.
4. Bendigs S., Salzer U., Lipford G., Wagner H., Heeg K. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur J Immunol 1999, 29:1209-1218.
5. Mao T., Lian Z., Selmi C., Ichiki Y., Ashwood P., Ansari A., et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005, 42:802-808.
6. Azulay-Debby H., Edry E., Melamed D. CpG DNA stimulates autoreactive immature B cells in the bone marrow. Eur J Immunol 2007, 37:1463-1475.
7. Chaturvedi A., Dorward D., Pierce S. The B cell receptor governs the subcellular location of toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008, 28:799-809.
8. Edwards J., Cambridge G., Abrahams V. Do self-perpetuating B lymphocytes drive human autoimmune disease?. Immunology 2001, 97:188-196.
9. Edwards J.C., Szczepanski L., Szechinski J., Filipowicz-Sosnowska A., Emery P., Close D.R., et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004, 350:2572-2581.
10. Gurcan H., Keskin D., Stern J., Nitzberg M., Shekhani H., Ahmed A. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009, 9:10-25.
11. Buhe V., Pers J., Marianowski R., Berthou C., Youinou P., Loisel S. Development of a murine model to dissect the CpG-oligonucleotide-enhancement of the killing of human B cells by rituximab. J Autoimmun 2010, 34:136-144.
12. Du X., Poltorak A., Wei Y., Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000, 11:362-371.
13. Chuang T., Ulevitch R. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000, 11:372-378.
14. Franch R., Cardazzo B., Antonello J., Castagnaro M., Patarnello T. Bargelloni. Full-length sequence and expression analysis of toll-like receptor 9 in the gilthead seabream (Sparus aurata L.). Gene 2006, 378:42-51.
15. Yao C., Kong P., Wang Z., Ji P., Cai M., Liu X., et al. Cloning and expression of two alternative splicing toll-like receptor 9 isoforms A and B in large yellow croaker, Pseudosciaena crocea. Fish Shellfish Immunol 2008, 25:648-656.
16. Wang E., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
17. Modrek B., Resch A., Grasso C., Lee C. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res 2001, 29:2850-2859.
18. Jaresova I., Rozkova D., Spisek R., Janda A., Brazova J., Sediva A. Kinetics of toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect 2007, 9:1359-1367.
19. Cavanagh L., Boyce A., Smith L., Padmanabha J., Filgueira L., Pietschmann P., et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 2005, 7:230-240.
20. Duke O.L., Hobbs S., Panayi G.S., Poulter L.W., Rasker J.J., Janossy G. A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule. Clin Exp Immunol 1984, 56:239-246.
21. Highton J., Hung N., Hessian P., Wilsher M. Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane. Rheumatology 2007, 46:811-814.
22. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
23. Bairoch A., Apweiler R., Wu C., Barker W., Boeckmann B., Ferro S., et al. The universal protein resource (UniProt). Nucleic Acids Res 2005, 33:154-159.
24. Thompson J., Higgins D., Gibson T., Clustal W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
25. Zheng Z., Schwartz S., Wagner L., Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol 2000, 7:203-214.
26. Hock B., Starling G., Daniel P., Hart D. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. Immunology 1994, 83(4):573-581.
27. Emanuelsson O., Nielsen H., Brunak S., Von Heijne G. Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol 2000, 300:1005-1016.
28. Bendtsen J., Nielsen H., Von Heijne G., Brunak S. Improved prediction of signal peptides: signalP 3.0. J Mol Biol 2004, 340:783-795.
29. Wu S., Skolnick J., Zhang Y. Ab initio modeling of small proteins by iterative TASSER simulations. BMC Biol 2007, 5:17.
30. Zhang Y. Template-based modeling and free modeling by I-TASSER in CASP7. Proteins 2007, 8:108-117.
31. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008, 9:40.
32. Moreland J., Grmada A., Buzk O., Zhang Q., Bourne P. The molecular biology toolkit (mbt): a modular platform for developing molecular visualization applications. BMC Bioinformatics 2005, 6:21.
33. Lappalainen P., Kessels M., Cope M., Drubin D. The ADF homology (ADF-H) domain: a highly exploited actin-binding module. Mol Biol Cell 1998, 9:1951-1959.
34. Highton J., Kean A., Hessian P.A., Thomson J., Rietveld J., Hart D. Cells expressing dendritic cell markers are present in the rheumatoid nodule. J Rheumatol 2000, 27:339-346.
35. Bell J., Mullen G., Leifer C., Mazzoni A., Davies D., Segal D. Leucine-rich repeats and pathogen recognition in toll-like receptors. Trends Immunol 2003, 24:528-533.
36. Wei T., Gong J., Jamitzky F., Heckl W., Stark R., Rossle S. Homology modeling of human toll-like receptors TLR7, 8, and 9 ligand-binding domains. Protein Sci 2009, 18:1684-1691.
37. Peter M., Kubarenko A., Weber A., Dalpke A. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J Immunol 2009, 182:7690-7697.
38. Ewald S., Lee B., Lau L., Wickliffe K., Shi G., Chapman H., et al. The ectodomain of toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008, 456:658-662.
39. Park B., Brinkman M., Spooner E., Lee C., Kim Y., Ploegh H. Proteolytic cleavage in an endosomal compartment is required for activation of toll-like receptor 9. Nat Immunol 2008, 9:1407-1414.
40. Choe J., Kelker M., Wilson I. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005, 309:581-585.
41. Latz E., Verma A., Visintin A., Gong M., Sirois C., Klein D., et al. Ligand-induced conformational changes allosterically activate toll-like receptor 9. Nat Immunol 2007, 8:772-779.
42. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G., Wagner H., et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 2004, 34:2541-2550.
43. Liu L., Botos I., Wang Y., Leonard J., Shiloach J., Segal D., et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008, 320:379-381.
44. Lazarus R., Klimecki W., Raby B., Vercelli D., Palmer L., Kwiatkowski D., et al. Single-nucleotide polymorphisms in the toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003, 81:85-91.
45. Kikuchi K., Lian Z., Kimura Y., Selmi C., Yang G., Gordon S., et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005, 24:347-352.
46. Zarember K., Godowski P. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002, 168:554-561.
47. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168:4531-4537.
48. Kikuchi K., Lian Z., Yang G., Ansari A., Ikehara S., Kaplan M., et al. Bacterial CpG induces hyper-IgM production in CD27 (+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005, 128:304-312.
49. Bernasconi N., Onai N., Lanzavecchia A. A role for toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naïve cells and constitutive expression in memory B cells. Immunobiology 2003, 101:4500-4504.
50. Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell triggering enhances immunoglobulin production. Immunology 2009, 128:573-579.
51. Monsalve M., Wu Z., Adelment G., Puigserver P., Fan M., Spiegelmn B. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 2000, 6:307-316.
52. Takeshita F., Suzuki K., Sasaki S., Ishii N., Klinman D., Ishii K. Transcriptional regulation of the human TLR9 gene. J Immunol 2004, 173:2552-2561.
53. Thompson C., Wang C., Ho I., Bohjanen P., Petryniak B., June C., et al. Cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol 1992, 12:1043-1053.
54. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R., Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments. Eur J Immunol 2002, 32:1958-1968.
55. Gewirtz A., Navas T., Lyons S., Godowski P., Madara J. Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001, 167:1882-1885.
56. Ojala P., Paavilainen V., Vartiainen M., Tuma R., Weeds A., Lappalainen P. The two ADF-H domain of twinfilin play functionally distinct roles in interactions with actin monomers. Mol Biol Cell 2002, 13:3811-3821.
57. Zhang Q., Itagaki K., Hauser C. Mitochondrial DNA is released by shock and activates neutrophils via p38 MAP-kinase. Shock 2009, doi:10.1097/SHK.0b013e3181cd8c08.
58. Hemmi H., Kaisho T., Takeda K., Akira S. The roles of toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003, 170:3059-3064.
59. Verthelyi D., Ishii K., Gursel M., Takeshita F., Klinman D. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 2001, 166:2372-2377.
60. Verthelyi D., Zeuner R. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol 2003, 24:519-522.
61. Agren J., Thiemermann C., Fosters S., Wang J., Aasen A. Cytokine responses to CpG DNA in human leukocytes. Scand J Immunol 2006, 64:61-68.
62. Klinman D., Yi A., Beaucage S., Conover J., Krieg A. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci U S A 1996, 93:2879-2883.